Asymchem
Latest round
- Series B
Last raised
- Dec 2012
Total raised
- $5.4M
Investors
- 4
About Asymchem
Founded in 1998 and based in Tianjin, China, Asymchem Inc. operates as a pharmaceutical company that focuses on the development and production of new drugs and APIs. The company has 8 R&D and production bases, as well as more than 20 R&D, production, and sales subsidiaries and offices located in Tianjin, Jilin, Shanghai, and other places. It cooperated with global pharmaceutical companies such as Pfizer, Merck, AbbVie, etc. Hao Hong, the chairman and CEO of the company, graduated from the Chinese Academy of Medical Sciences and is also a visiting professor at Sichuan University. In December 2021, the company was listed on the Hong Kong Stock Exchange.31 billion. The company is mainly engaged in the research and development of new drugs and drug APIs. It combines molecular biology technology, fermentation technology, and process development technology to provide users with carbapenem drugs, cGMP APIs and other products. The products can be used to treat major diseases such as antiviral, anticancer, cardiovascular and cerebrovascular diseases, and diabetes. The company generates revenue by providing new drugs and APIs.
Who invested in Asymchem
4 investors across 2 rounds
See all investors in Asymchem
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Asymchem
Who invested in Asymchem?
Asymchem has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Asymchem raised?
Asymchem has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Asymchem last raise money?
Asymchem's most recent round on record is a Series B, in Dec 2012.
What does Asymchem do?
Founded in 1998 and based in Tianjin, China, Asymchem Inc.
Where is Asymchem headquartered?
Asymchem is headquartered in Tianjin, China.
Which VCs invest in companies like Asymchem?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Asymchem's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Asymchem? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.